Recent Headlines
Within Pharmaceuticals
Baxa Corporation Launches New Web Site
Baxa announces the launch of its new corporate Web site with enhanced user features and technical content. The site provides a global platform for information exchange, product marketing, public relations, and sales and technical support for health-system pharmacists and nurses, as well as pharmaceutical industry representatives. - January 31, 2008 - Baxa Corporation
Alleviate the Symptoms of Depression Successfully
Mitamins has launched a specific supplement formula from Dr. Balch focused on alleviating the symptoms of depression. This natural treatment formula includes essential natural ingredients that can promote a positive and enduring healthy mental state, such as Choline Bitartrate, Inositol, PABA, DHEA, Omega - 3 Fatty Acids, St. John's Wort Extract, and Pantothenic Acid. - January 31, 2008 - Mitamins Inc.
Natural Supplement for Diabetes Sufferers
At Mitamins, a specific supplement formula from Dr. Balch designed to target Diabetes has been launched. This natural treatment formula includes ingredients that can optimize blood sugar control and may improve the overall health condition. Chromium in it helps to regulate blood sugar level and indirectly affects level of fats in the blood, and taurine may improve insulin sensitivity and decrease cholesterol level. - January 30, 2008 - Mitamins Inc.
Ron Newcomb Named President & CEO of Resveratrol, Inc.
Ron Newcomb has been named president and CEO of Resveratrol, Inc., a nutraceutical company. Newcomb plans to increase sales of Resveratrol’s three products, NutraGrape™, a dietary nutritional supplement made of Muscadine grape seeds; The Vine® facial cream and The Vine® body lotion. Muscadine grape seeds have very high levels of antioxidants, which help fight free radical damage to your body. - January 29, 2008 - NutraGrape
Conquer High Cholesterol Thoroughly
Mitamins has launched a new supplement formula from Dr. Balch especially designed to target High Cholesterol. This natural treatment formula is a comprehensive approach to lower cholesterol, aiming for optimum cardiovascular health. Red Yeast Rice in the formula can inhibit cholesterol production in the liver and may lower cholesterol levels. - January 29, 2008 - Mitamins Inc.
AnaSpec Introduces 9 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection. Anti-AKT pan (IN) - Cat# 54320, 50 µg Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; bovine; zebrafish; Applications: WB Anti-AKT pan (NT) - Cat#... - January 27, 2008 - AnaSpec, EGT Group
Dr Balch High Blood Pressure Formula
Mitamins launches Dr Balch’s High Blood Pressure condition specific supplement formula: Vitamin C 100mg, Calcium 100mg, Magnesium 50mg, CoQ-10 60mg, Flax Seed Powder 50mg, Bioflavonoid Concentrate 100mg, Garlic Extract 100mg, Hawthorn Extract 250mg, Reishi Extract 50mg, Taurine... - January 27, 2008 - Mitamins Inc.
Growing Mobile Cath Lab Market Leads to Expansion at Modular Devices Inc.
Move to larger production facility will allow company to keep up with the growing demand for Mobile and Modular Cardiac/Vascular & EP Lab rentals. - January 26, 2008 - Modular Devices Inc.
Xcelience Expands Its Early Drug Development Capabilities
The Tampa-based CRO is first to acquire next generation Xcelodose. - January 26, 2008 - Xcelience, LLC
Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock® Set Saver
New Baxa eCampaign targets IV Nurses to introduce the PadLock Set Saver and honors nurses for their dedication to patients. The PadLock Set Saver device is designed to promote best practice for aseptic IV administration set storage, preventing contamination of the administration set when disconnected from the patient. The Set Saver also eliminates the use of IV administration set caps, which are a known choking hazard – especially in pediatric applications. - January 25, 2008 - Baxa Corporation
Anavex Outlines Corporate Milestones, Drug Advancement Plans for 2008
Anavex Life Sciences Corp. achieved significant development of its lead drug candidates and growth of its management and scientific teams during 2007. - January 24, 2008 - Anavex Life Sciences Corp.
The First Fully Cementless Knee Replacement Performed at CentraState by Orthopedic Surgeons from the Advanced Orthopedics and Sports Medicine Institute in Freehold, NJ
On Tuesday, November 20th, Dr Michael Greller and Dr Alan Nasar, orthopedic surgeons from the Advanced Orthopedics and Sports Medicine Institute in Freehold, New Jersey, performed the first fully cementless, minimally invasive total knee replacement using trabecular metal technology in the history of CentraState Medical Center, Freehold, NJ. - January 24, 2008 - Advanced Orthopedics and Sports Medicine Institute, PC
Minimizing and Treating Sebaceous Cysts
Mitamins has launched a new supplement formula from Dr. Balch especially designed to target Sebaceous Cysts. This natural treatment formula is targeted at building the body's natural clearance and preventative processes, which work against sebaceous cysts. The formula includes all the essential natural ingredients to target this condition. - January 24, 2008 - Mitamins Inc.
AnaSpec Announces a Broad Selection of T-Cell Epitopes
AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled. - January 23, 2008 - AnaSpec, EGT Group
Control Lupus Symptoms, Lead a Full Life
At Mitamins, a new supplement formula targeted at Lupus from Dr. Balch has been launched. This natural lupus treatment formula is designed to control the symptoms of lupus as well as promote overall health. Botanicals, such as ginger, having strong anti-inflammatory properties are included. The... - January 23, 2008 - Mitamins Inc.
Relief from Tinnitus
Dr. Balch has launched a Mitamins supplement designed to target Tinnitus. This supplement contains Vitamins B-12 and B-6, as well as the nutrients Thiamin, Riboflavin, Niacin, Folate, Biotin, Magnesium, Zinc, Copper, and Pantothenic Acid. It also includes Choline Bitartrate, Inositol, PABA, and Gingko Extract. - January 21, 2008 - Mitamins Inc.
Improve Quality of Life with Supplement Targeting Hypothyroidism
Mitamins launches a formula by Dr. Balch that is specified to target Hypothyroidism. It contains Vitamins A, C, D, E, K, B-6, and B-12, as well as the nutrients Calcium, Iodine, Magnesium, Thiamin, Riboflavin, Niacin, Folate, Biotin, Copper, Selenium, Maganese, Chromium, Potassium, Pantothenic... - January 21, 2008 - Mitamins Inc.
Defeat Narcolepsy the Natural Way
Mitamins launches a new formula from Dr. Balch that is specified to target Narcolepsy. This supplement contains a complete spectrum of B vitamins, which are especially nourishing to the brain: Thiamin, Riboflavin, Niacin, Vitamin B12, Folate, Pantothenic Acid and Vitamin B6. The formula also includes an Amino Acid Mix, as well as L-Tyrosine, L-Glutamine, Lecithin and Ginkgo Extract. Necessary minerals such as Calcium, Magnesium and Chromium are included as well. - January 21, 2008 - Mitamins Inc.
Supplement for Emphysema: Enhance and Support Lung Health
From Sunnyvale, California - At Mitamins, a new supplement formula from Dr. Balch, which is targeted at Emphysema has been launched. This natural emphysema formula is focused on lung system recovery and repair. Botanicals such as Ginkgo Biloba, used to help with peripheral circulation, are included alongside powerful immunity-enhancing components such as Astragalus. Smoking- and stress-related nutritional deficiencies are addressed with a variety of essentials. - January 21, 2008 - Mitamins Inc.
Calcium Supplementation and Heart Attack Risk? Vitamin K2 May be a Solution.
Industry expert Scott Rosenbush strongly recommends vitamin K2 supplementation to help ensure bone and heart health. As the most bioactive and longest lasting form of vitamin K, menaquinone-7 is ideal for dietary supplements and functional foods. - January 19, 2008 - P.L. Thomas & Co., Inc.
Anavex Strengthens Board of Directors
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors. - January 16, 2008 - Anavex Life Sciences Corp.
Anavex 7-1037 Demonstrates Chemotherapeutic Potential Without Toxic Side Effects for the Treatment of Colorectal Cancer, Other Types of Solid Tumors
ANAVEX 7-1037 has been shown to kill human HCT116 colon cancer cells in advanced pre-clinical studies. - January 16, 2008 - Anavex Life Sciences Corp.
Anavex Advances Drug Candidate for Treatment of Alzheimer's Disease
Results from animal model testing demonstrate ANAVEX 1-41 has significant neuroprotective and anti-amnesic benefits. - January 16, 2008 - Anavex Life Sciences Corp.
Trevigen Launches Cultrex BME PathClear
Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. - January 11, 2008 - Trevigen, Inc.
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug
Enters Service Agreement with Advinus Therapeutics, India to Validate Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol. Strategy is to Bolster Caprospinol Alzheimer's Data Package to Out-License to Big Pharma and Expand IND Application to Enter Human Trials. Samaritan... - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals
Axium Awarded Phase III Clinical Trial Management Contract for OxThera’s Oxabact™
Axium Healthcare Pharmacy announced today that it has been awarded the clinical trial management contract for OxThera’s Oxabact™. Oxabact™ is manufactured by OxThera. - January 09, 2008 - Axium Healthcare Pharmacy, Inc.
Successful CentraState HealthWatch Cable TV Pilot Show Featuring Freehold NJ Orthopedic Surgeon Dr Alan Nasar Rewarded with Extended Life and Wider Distribution
The CentraState HealthWatch cable TV show featuring Freehold, NJ orthopedic surgeon Dr Alan Nasar, has been extended through January across an increased number of New Jersey television stations. Alan S. Nasar MD, a fellowship-trained joint replacement orthopedic surgeon at the Advanced Orthopedics and Sports Medicine Institute in Freehold, features in one segment of the half-hour show discussing advances in joint replacement surgery and pain management with host Gary Gellman. - January 07, 2008 - Advanced Orthopedics and Sports Medicine Institute, PC
DDC's Laboratory Director Now Chair of AABB Parentage Testing Program
Effective January 1, 2008, DDC's Laboratory Director, Dr. Michael Baird, is chairman of the Chair of the Relationship Testing Standards Program Unit of the AABB (formerly American Association of Blood Banks). In this capacity, Dr. Baird is leading the committee to develop the 9th edition of the... - January 05, 2008 - DNA Diagnostics Center
AnaSpec Introduces Ten New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA... - January 04, 2008 - AnaSpec, EGT Group
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
The U.S. Food and Drug Administration (FDA) has completed its regulatory review of Samaritan's IND (Investigational New Drug) application for Cushing's syndrome SP-6300 and declared it has not identified any deficiencies in its IND filing. Accordingly, Samaritan can proceed with its proposed Phase II clinical study of Cushing's syndrome SP-6300's efficacy in patients experiencing Hypercortisolism. - January 04, 2008 - Samaritan Pharmaceuticals
Samaritan Expands Revenue Opportunities with Marketing Authorization Approval for HIV Drug Amphocil in Cyprus
Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health... - January 03, 2008 - Samaritan Pharmaceuticals
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals
EUSA Pharma Signs Exclusive Distribution Agreement with Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals
Avoiding Steroids and Their Side Effects Should be Component in New Year’s Resolution of Athletes, Law Enforcement and Paramilitary
Unparalleled drug-free gains in strength, stamina and mental performance attainable through natural energetic alternative to steroids and banned performance enhancing drugs providing powerful ergogenic effects rivaling steroids, blood doping and other dangerous performance enhancement techniques while enhancing deep delta sleep, cardiovascular efficiency, cellular repair and mental acuity. - January 01, 2008 - EarthPulse Tech, LLC
‘Harsh Goenka Takes a Keen Note of Suchitra Krishnamurty’s Arty Comments’
The annual art camp by the RPG Academy of Art concluded with a warm brunch at the Marve beach house today. Pristine white was the theme of the locale and the breezy touch of sea winds along with the live band playing some groovy numbers got the enchantment heightened. After the week-long camp, the... - December 30, 2007 - RPG
Whole Youth Adds Annique Herbal Rooibos Red Tea and Green Tea
Whole Youth brings the Annique Rooibos red tea, green tea and blended herbal teas to the USA. The complete Annique range is manufactured in South Africa from the Rooibos (red bush) plant and includes cosmetics skin care as well as the newly introduced line of Rooibos teas. - December 29, 2007 - Whole Youth
"Clinical and Economical Considerations for Iv Push Drug Delivery" by Industry Expert Richard Rosenfeld is Now Accessible on Expert411.com for Media and Professional Use
The “Clinical and Economical Considerations For IV Push Drug Delivery” technical paper – authored by Industry Expert Richard Rosenfeld, RPh, MBA, for Baxa Corporation – is now accessible at Expert411.com for media and professional reference. The paper is an overview of the historical background for IV push and a model for implementation of a successful program. - December 27, 2007 - Baxa Corporation
Stop Smoking with Acupuncture Hypnosis and Neuroprogramming
A new product for Stop Smoking with AcuAids providing a comprehensive approach. - December 21, 2007 - AcuAids
AnaSpec Introduces Sixteen New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine... - December 20, 2007 - AnaSpec, EGT Group
Survey Verifies Link Between Nurses' Illness and Occupational Exposure
Scientists recently released the results of the first ever national survey which assessed nurses’ extent and frequency of exposures to common health care hazards. - December 19, 2007 - Carmel Pharma
AnaSpec Introduces First Colorimetric SensoLyte™ MMP Assay Kit
AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, EGT Group
2008: The Year of the Gnu?
A “Gnu” movement is taking hold across the country. People everywhere are chanting, “I want my fiber”. Dietary fiber, that is. People nationwide are proclaiming that the delicious Flavor & Fiber Bars, made by Gnu Foods, are the inspiration for their fiber-obsession. They... - December 18, 2007 - Gnu Foods, LLC
AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides
AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, EGT Group
Freehold Orthopedic Surgeon Dr. Alan Nasar Gives the Final Public Lecture of the Current Series by the Advanced Orthopedics and Sports Medicine Institute, Freehold, NJ
Freehold Orthopedic surgeon Alan S. Nasar, MD delivered the final lecture for the year “Hip Arthroscopy, Hip Resurfacing and Hip Replacement; Are You a Candidate?” to a welcoming audience, mainly members of the local community, on Tuesday, December 11th, at the CentraState Healthcare Center in Freehold, New Jersey. Dr Nasar, Director of the Total Joint Center of New Jersey, is one of the team of orthopedic surgeons from the Advanced Orthopedics and Sports Medicine Institute in Freehold, NJ. - December 16, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC
AnaSpec Introduces 10 New Catalog Antibodies
Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2... - December 15, 2007 - AnaSpec, EGT Group
The Holiday Gift for the Pet Who Has Everything
Pulsed magnetic fields provide strong anti-aging effects while enhancing physical performance in older pets where trauma, arthritis or age related joint deformity has resulted in chronic pain, loss of mobility and subsequent changes in behavior. - December 14, 2007 - EarthPulse Tech, LLC